Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.2 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.3 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.3 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |